Ardent Health annual return on equity
2023
2024
2025
Ardent Health Return on Equity (ROE) Growth & History (ARDT)
Ardent Health's return on equity was 11.23% for fiscal 2025.
View full Ardent Health company overviewArdent Health annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 11.23% | −12.11 pp |
| 2024 | 2024-12-31 | 23.34% | +17.04 pp |
| 2023 | 2023-12-31 | 6.30% | — |
Ardent Health quarterly return on equity
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 1.26% | −4.75 pp |
| Q1 2026 | 2026-03-31 | 3.04% | −0.55 pp |
| Q4 2025 | 2025-12-31 | 3.56% | −7.13 pp |
| Q3 2025 | 2025-09-30 | −1.88% | −4.90 pp |
| Q2 2025 | 2025-06-30 | 6.00% | −0.06 pp |
| Q1 2025 | 2025-03-31 | 3.59% | — |
| Q4 2024 | 2024-12-31 | 10.69% | — |
| Q3 2024 | 2024-09-30 | 3.02% | — |
| Q2 2024 | 2024-06-30 | 6.06% | — |
Ardent Health return on equity trends
Between the periods ended 2023-12-31 and 2025-12-31, Ardent Health's return on equity increased from 6.30% to 11.23%, a change of +4.92 percentage points. The latest reported quarter, Q2 2026, shows 1.26%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ardent Health source filings ↗